Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release relating to the expiry of the HSR Act process and the successful consummation of Winlevi(r) (clascoterone cream 1%) agreement. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Submission Of Sustainability Report Of Sun Pharmaceutical Industries Limited ('The Company') For The Financial Year 2020-21
We are submitting herewith the Sustainability Report of the Company for the financial year 2020-21, which we shall be releasing after sending this letter to you. The Sustainability Report of the Company shall also be made available on the website of our Company. This is for your information and dissemination. Sun Pharmaceutical Industries Ltd - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 24, 2021 for Raksha Sudhir Valia SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Q1FY22: Domestic portfolio delivers for pharma majors; worry over US headwinds
Barring Sun Pharma, most stocks lost 5-24 per cent since July 23 SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting. Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Newspaper Publication
As per attached letter. Sun Pharmaceutical Industries Ltd - 524715 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith a copy of the transcript of the Company's Q1FY22 earnings conference call. Sun Pharmaceutical Industries Ltd - 524715 - Notice Of The 29Th Annual General Meeting Of The Company, Scheduled To Be Held On Tuesday, August 31, 2021 At 03.00 P.M. IST Through Video Conferencing/Other Audio-Visual Means
We are submitting herewith the Annual Report including the Business Responsibility Report of the Company for the financial year 2020-21 alongwith the Notice of the 29th Annual General Meeting of the Company, as per attached letter.